Doctors warn of disaster if the epidemic continues to spread and increase resistance

Doctors warn of disaster if the epidemic continues to spread and increase resistance

Official report: Six groups of antibiotics are no longer useful  for cholera treatment

An official report from the Sanaa Central Laboratory revealed that cholera resistance has been fully developed for six antibiotic families this year, while its sensitivity to four other families available in the Yemeni market is still ongoing.

A formal report issued by the National Centre for Public Health Laboratories, entitled (Antibiotic Cholera allergy test), was obtained by Al-Masdar online , which previously gave high sensitivity to most of the antibiotics used.

He noted that this sensitivity began to decline in October 2016 for some groups especially (Macrolides ) and other groups and then began to resist bacteria for these medications in October 2017.

The report indicated that cholera bacteria had recently become fully resistant to these antibiotics in 2019, meaning that they were no longer feasible for cholera treatment.

Antibiotics include six groups--the Macrolides --penicillin--the beta-lactamase inhibitors--the third and fourth generation of cephalosporin--and the folate pathway inhibitors.

The report explained that bacteria are still sensitive to some antibiotic families, which include the fluoroquinolones Group (ciprofloxacin)-The Phenicol group (Chloromphenicol)-and the tetracycline group (doxocyline, Minoscycline, Tetracycline) and finally polypeptide group ( Colstein sulphate.

Doctors have seen the report in comments to Al-Masdar online that the reduction of cholera sensitivity to all these groups is a serious development about the efficacy of medicines in the fight against the epidemic.

They warned that continuing to deal with cholera in this way will increase their resistance and may become resistant to all antibiotics in the coming years, which means a disaster that could kill tens of thousands of people infected with the disease.

They explained that the report was not general and that the resistance to antibiotics might be uneven from one place to another, but that did not diminish the severity of the epidemic.

Doctors were surprised to find the cholera bacteria constantly at a time when citizens were waiting to be eradicated despite the availability of an integrated database of endemic areas, which required a rigorous action plan to combat its causes.

They called on Authorities  in the Yemeni government and the World Health Organization (WHO) to start serious cholera treatments, including clean water, comprehensive environmental sanitation for water sources, sanitation and hygiene education.

They also called on the World Health Organization (WHO) to prioritize the allocation of humanitarian response to cholera vaccines, which provide for a five-year period of serious disease prevention to address the health catastrophe caused by the outbreak of the epidemic.

Cholera infections  have reached more than 260,000, with some 530 deaths from the beginning of the year to the end of April, amid warnings of an epidemic that may be the worst in history.


Print Send